Why Consider Self-Sampling for Cervical Cancer Screening in Low- and Middle-Income Countries
Bibliographic Data
| ID | 15744976 |
|---|---|
| Authors | Victoire Fokom Defo (Université de Yaoundé I, corresponding author), Joël Fokom Domgue (0000-0002-4722-9262, The University of Texas MD Anderson Cancer Center) |
| Year | 2020 |
| Volume | 22 |
| Issue | 2 |
| Pages | E116-125 |
| Publication date | 2020-02-01 |
| Peer Reviewed | Yes |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | The AMA Journal of Ethic (JOURNAL) |
| Journal identifiers | ISSN: 2376-6980 • E-ISSN: 2376-6980 |
| Publisher | American Medical Association (PUBLISHER • US) |
| DOI | 10.1001/amajethics.2020.116 |
| PMID | 32048582 |
| OpenAlex | W3003972315 |
| Language | EN |
| Citations received | 2 |
| References cited | 3 |
Molecular detection of high-risk human papillomavirus (HPV) in genital cells is being widely endorsed as a preferred tool for cervical cancer screening globally. In low- and middle-income countries (LMICs) where cervical cancer remains a leading killer, HPV testing is an appealing, accessible alternative to traditional cytology (ie, Pap smear) screening that enables women to self-collect specimens. This article examines self-sampling and its suitability as a strategy for cervical cancer prevention in LMICs that would promote equitable access to cervical cancer screening
Cancer · Cervical cancer · Developing country · Economic growth · Economics · Low and middle income countries · Sampling (signal processing · Telecommunications · Cervical Cancer and HPV Research · Colorectal Cancer Screening and Detection · Computer Science · Global Cancer Incidence and Screening · Medicine · Internal Medicine
| Unique citing works | 2 |
|---|---|
| Citations per year | 0.4 |
| Citation span | 2021 - 2025 (5) |
| Citation velocity | recent |
| Highly cited | No |
| Citation types | Neutral: 2 |